IOBT — IO Biotech Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for IO Biotech, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	PROSPECTUS	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Cash and Short Term Investments	7.85	3.4	212	143	143
Net Total Receivables	1.23	1.5	2.09	1.53	1.13
Prepaid Expenses
Total Other Current Assets
Total Current Assets	9.4	5.63	222	148	147
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	—	—	—	3.23	3.11
Other Long Term Assets
Total Assets	9.42	5.65	222	152	151
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	10.8	3.05	10.3	10.7	15.7
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	10.9	3.05	10.4	13	17.6
Non Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	-1.47	2.6	212	139	133
Total Liabilities & Shareholders' Equity	9.42	5.65	222	152	151
Total Common Shares Outstanding